chemotherapy
Showing 1 - 25 of 135
NLR and Its Association With Efficacy of Immunochemotherapy in
Recruiting
- Esophageal Squamous Cell Carcinoma
- +2 more
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Nov 10, 2023
Tislelizumab Combined With Chemotherapy in First-line Treatment
Active, not recruiting
- Tislelizumab
- +3 more
-
Beijing, ChinaCancer Institute and Hospital, Chinese Academy of Medical Scienc
Sep 6, 2023
Neoadjuvent, PD-1 Inhibitor, Chemo Trial in Xi'an (Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin)
Recruiting
- Neoadjuvent
- +3 more
- Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin
-
Xi'an, Shaanxi, China
- +2 more
Aug 17, 2023
Bladder Cancer, Cystectomy, Chemo Trial (Dietary and Exercise Intervention)
Not yet recruiting
- Bladder Cancer
- +2 more
- Dietary and Exercise Intervention
- (no location specified)
Aug 15, 2023
Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, Radiotherapy Trial (radiation, drug, biological)
Not yet recruiting
- Nasopharyngeal Carcinoma
- +3 more
- Intensity Modulated Radiation Therapy
- +3 more
- (no location specified)
Jul 11, 2023
Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,
Not yet recruiting
- Metastatic Gastric Adenocarcinoma
- +2 more
- nal-IRI /Experimental
- +2 more
- (no location specified)
Jun 25, 2023
Chemo, Colorectal Cancer, Intestinal Mucositis Trial (Losartan 50mg Tab)
Not yet recruiting
- Chemotherapy
- +3 more
- Losartan 50mg Tab
- (no location specified)
May 13, 2023
Anxiety, Breast Cancer, Chemo Trial (Music therapy)
Not yet recruiting
- Anxiety
- +2 more
- Music therapy
- (no location specified)
May 4, 2023
Pegfilgrastim, Bone Pain, Chemo Trial (Timing of pegfilgrastim administration)
Not yet recruiting
- Pegfilgrastim
- +4 more
- Timing of pegfilgrastim administration
- (no location specified)
Apr 21, 2023
Immunotherapy, Chemo Trial in Guandong (Camrelizumab)
Recruiting
- Immunotherapy
- Chemotherapy
-
Guandong, Guangdong, ChinaNanfang Hospital, Southern Medical University
Apr 22, 2023
Chemo, Radiation Therapy Trial in Fuzhou (Camrelizumab, Paclitaxel, Cisplatin)
Not yet recruiting
- Chemotherapy
- Radiation Therapy
- Camrelizumab
- +3 more
-
Fuzhou, ChinaFujian Medical University Union Hospital
Apr 6, 2023
Esophageal Cancer, Radiation Therapy, Immunotherapy Trial in Taizhou (Toripalimab, Tegafur, IMRT)
Recruiting
- Esophageal Cancer
- +3 more
- Toripalimab
- +2 more
-
Taizhou, Zhejiang, China
- +1 more
Apr 15, 2023
Nasopharyngeal Carcinoma, Leucogen, Chemo Trial in Guangzhou (5-fu, Lobaplatin, Placebo)
Not yet recruiting
- Nasopharyngeal Carcinoma
- +3 more
- 5-fu
- +3 more
-
Guangzhou, Guangdong, ChinaDepartment of Radiation Oncology, Sun Yat-Sen University Cancer
Mar 10, 2023
Colorectal Cancer, Oncologic Complications, Comprehensive Geriatric Assessment Trial (Targeted specialized physical group-based
Not yet recruiting
- Colorectal Cancer
- +21 more
- Targeted specialized physical group-based exercise and Comprehensive Geriatric Assessement
- (no location specified)
Jan 25, 2023
Malignant Tumor, Chemo Trial (Tik Tok)
Not yet recruiting
- Malignant Tumor
- Chemotherapy
- Tik Tok
- (no location specified)
Jan 11, 2023
Acupuncture, Taste Disorders, Dysgeusia Trial in Essen, Mannheim (Hypoglossal acupuncture, Sham acupuncture, Dietary
Recruiting
- Acupuncture
- +4 more
- Hypoglossal acupuncture
- +2 more
-
Essen, NRW, Germany
- +2 more
Dec 5, 2022
Pathological Tumor and Lymph Node Responses After Neoadjuvant
Completed
- Non Small Cell Lung Cancer
- +3 more
- Timing of drug administration
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Nov 24, 2022
Esophageal Squamous Cell Carcinomas, Concurrent Chemoradiotherapy, Immunotherapy Trial (chemo combined with PD-1 inhibitors)
Not yet recruiting
- Esophageal Squamous Cell Carcinomas
- +3 more
- chemotherapy combined with PD-1 inhibitors
- (no location specified)
Nov 17, 2022
Esophageal Squamous Cell Carcinoma, Esophagectomy, Radiotherapy Trial (Since the data were collected retrospectively, there were
Completed
- Esophageal Squamous Cell Carcinoma
- +3 more
- Since the data were collected retrospectively, there were no interventions
- (no location specified)
Oct 31, 2022
Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1 Trial in Shanghai (Toripalimab (anti-programmed death-1 inhibitor),
Recruiting
- Oral Squamous Cell Carcinoma
- +3 more
- Toripalimab (anti-programmed death-1 inhibitor)
- +4 more
-
Shanghai, Shanghai, ChinaNinth People's Hospital, Shanghai Jiao Tong University School of
Oct 8, 2022
Cancer, Chemo Trial in Nashville (Virtual reality therapy, Questionnaires, Measure heart rate)
Recruiting
- Cancer
- Chemotherapy
- Virtual reality therapy
- +3 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Sep 13, 2022
Colorectal Cancer Metastatic, Chemo Trial in France (Oncogramme®)
Recruiting
- Colorectal Cancer Metastatic
- Chemotherapy
- Oncogramme®
-
Amiens, France
- +13 more
Sep 10, 2022
Quality of Life and Cognitive Level in Breast Cancer Patients
Recruiting
- Physical Activity
- +3 more
-
Aydin, TurkeyAydın Adnan Menderes University Hospital
Jul 12, 2022
Neoadjuvent, PD-1 Inhibitor, Lung Cancer Trial in Xi'an (neoadjuvant PD-1 inhibitor, anlotinib combined with chemo)
Recruiting
- Neoadjuvent
- +4 more
- neoadjuvant PD-1 inhibitor, anlotinib combined with chemotherapy
-
Xi'an, ChinaTangdu Hospital, the Air Force Military University
May 26, 2022